Expression of prothrombinase/fibroleukin gene fg12 in lung impairment in a murine severe acute respiratory syndrome model

Virologica Sinica

Volumn 22, Issue 3, 2007, Pages 181-192

  Yan, Wei Ming ^a   Huang, Jia Quan ^a   Luo, Xiao Ping ^a   Ning, Qin ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Fibronogen like ptotein 2 (Fgl2); Lung impairment; Murine hepatitis virus strain 3(MHV 3); Severe acute respiratory syndrome (SARS)

Indexed keywords

BLOOD CLOTTING FACTOR 10A; FIBRIN; FIBRINOGEN LIKE PROTEIN 2; FIBROLEUKIN; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR; HOST FACTOR; MESSENGER RNA; NUCLEOCAPSID PROTEIN; PROTEIN; SERINE PROTEINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHIOLE; CELL INFILTRATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HISTOPATHOLOGY; INTERSTITIAL PNEUMONIA; LUNG ALVEOLUS EPITHELIUM; LUNG BLOOD VESSEL; LUNG PARENCHYMA; MICROVASCULATURE; MOUSE; MURINE HEPATITIS CORONAVIRUS; NONHUMAN; SEVERE ACUTE RESPIRATORY SYNDROME; SPLEEN; SURVIVAL RATE; THROMBOSIS; UPREGULATION; VIRUS NUCLEOCAPSID; VIRUS REPLICATION; VIRUS TITRATION; ACUTE LUNG INJURY; BAGG ALBINO MOUSE; CLINICAL EVALUATION; FIBRIN DEPOSITION; GENE EXPRESSION LEVEL; HYALINE MEMBRANE DISEASE; INFLAMMATION; INFLAMMATORY INFILTRATE; LUNG; LUNG ALVEOLUS; LUNG EMBOLISM; LUNG INFILTRATE; MRNA EXPRESSION LEVEL; MURINE HEPATITIS VIRUS; PROTEIN EXPRESSION LEVEL; TRACHEA; VIRUS PATHOGENESIS;

ANIMALIA; MURINAE; MURINE HEPATITIS VIRUS; MURINE HEPATITIS VIRUS STRAIN 3;

EID: 34347222920     PISSN: 10035125     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Booth C, Matukas L, Tomlinson G. 2003. Clinical features and short-term outcomes of 144 patients with SARS in Toronto Area. JAMA, 289: 2801-2809.
2. Chau T, Lee K, Yao H. 2004. SARS-associated viral hepatitis caused by a novel coronavirus: Report of three cases. Hepatology, 39: 302-310.
3. Chow K, Hsiao C, Lin T. 2004. Detection of severe acute respiratory syndrome-associated coronavirus in pneumocytes of the lung. Am J Clin Pathol, 121: 574-580.
4. Ding J, Ning Q, Liu M. 1997. Fuliminant hepatic failure hepatitis virus strain 3 infection: Tissue-specific expression of a novel fg12 prothrombinase. J Virol, 71: 9223-9230.
5. Ding Y, Wang H, Shen H, et al. 2003. The clinical pathology of severe acute respiratory syndrome (SARS): A report from China. J Pathol, 200 (3): 282-289.
6. Drosten C, Gunther S, Preiser W, et al. 2003. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med, 348 (20): 1967-1976.
7. Fouchier R, Kuiken T, Schutten M. 2003. Aetiology: Koch's postulates fulfilled for SARS virus. Nature, 423: 240.
8. Franks T, Chong P, Chui P. 2003. Lung pathology of severe acute respiratory syndrome (SARS): A study of 8 autopsy cases from Singapore. Hum Pathol, 34: 743-748.
9. Gillim-Ross L, Taylor J, Scholl D R, et al. 2004. Discovery of novel human and animal cells infected by the severe acute respiratory syndrome coronavirus by replication-specific multiplex reverse transcription-PCR. J Clin Microbiol, 42 (7): 3196-3206.
10. Glass W, Subbarao K, Murphy B. 2004. Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice. J Immunol, 173: 4030-4039.
11. Ksiazek T, Erdman D, Goldsmith C. 2003. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med, 348: 1953-1966.
12. Lamontagne L, Jolicoeur P. 1991. Mouse hepatitis virus 3-thymic cell interactions correlating with viral pathogenicity. J Immunol, 146 (9): 3152-3159.
13. Lee N, Hui D, Wu A. 2003. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med, 348: 1986-1994.
14. Levy G, Liu M, Ding J. 2000. Molecular and functional analysis of the human prothrombinase gene (HFGL2) and its role in viral hepatitis. Am J Pathol, 156: 1217-1225.
15. Lin Y, Shen X, Yang R. 2003. Identification of an epitope of SARS-coronavirus nucleocapsid protein. Cell Res, 13: 141-145.
16. MacPhee P, Dindzans V, Fung L. 1985. Acute and chronic changes in the microcirculation of the liver in inbred strains of mice following infection with mouse hepatitis virus type 3. Hepatology, 5: 649-660.
17. Marra M, Jones S, Astell C. 2003. The genome sequence of SARS-associated coronavirus. Science, 300: 1399-1404.
18. Marsden P, Ning Q, Fung L. 2003. The fg12/fibroleukin prothrombinase contributes to immunologically mediated thrombosis in experimental and human viral hepatitis. J Clin Invest, 112: 58-66.
19. McAuliffe J, Vogel L, Roberts k, et al. 2004. Replication of SARS coronavirus administered into the respiratory tract of African Green, rhesus and cynomolgus monkeys. Virology, 330 (1 ): 8-15.
20. Ng L, Hibberd M, Ooi E. 2004. A human in vitro model system for investigating genome-wide host responses to SARS coronavirus infection. BMC Infect Dis, 4: 34.
21. Ning Q L X, Yan WM. 2004. A method to establish a murine model of fulminant viral hepatitis [Patent]. China.
22. Ning Q, Sun Y, Han M. 2005. Role of Fg12 Prothrombinase/ Fibroleukin in Experimental and Human Allograft Rejection. J Immunol, 174: 7403-7411.
23. Osterhaus A, Fouchier R, Kuiken T. 2004. The aetiology of SARS: Koch's postulates fulfilled. Philos Trans R Soc Lond B Biol Sci, 359: 1081-1082.
24. Peiris J, Chu C, Cheng V. 2003. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: A prospective study. Lancet, 361: 1767-1772.
25. Peiris J, Lai S, Poon L. 2003. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet, 361: 1319-1325.
26. Pope M, Rotstein O, Cole E, et al. 1995. Pattern of disease after murine hepatitis virus strain 3 infection correlates with macrophage activation and not viral replication. J Virol, 69: 5252-5260.
27. Roberts A, Vogel L, Guarner J, et al. 2005. Severe acute respiratory syndrome coronavirus infection of golden Syrian hamsters. J Virol, 79 (1): 503-511.
28. Rowe T, Gao G, Hogan R. 2004. Macaque model for severe acute respiratory syndrome. J Virol, 78: 11401-11404.
29. Snijder E, Bredenbeek P, Dobbe J. 2003. Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J Mol Biol, 331: 991-1004.
30. To K, Tong J, Chan P. 2004. Tissue and cellular tropism of the coronavirus associated with severe acute respiratory syndrome: An in-situ hybridization of fatal cases. J Pathol, 202: 157-163.
31. Wu S, Du C, Wan P. 2003. The genome comparison of SARS-CoV and other coronaviruses. Hereditas (Beijing), 25: 373-382. (in Chinese)
32. Yin C, Wang C, Tang Z. 2004. Clinical analysis of multiple organ dysfunction syndrome in patients suffering from SARS. Chin Critical Care Med, 16: 646-650. (in Chinese)
33. Zhang J. 2003. Severe acute respiratory syndrome and its lesions in digestive system. World J Gastroenterol, 9: 1135-1138.
34. Zhao L, Xing H, Xu L. 2004. Effect of SARS-associated coronavirus on peripheral blood picture and liver function. Chin Critical Care Med, 16: 660-663. (in Chinese)
35. Zhao P, Cao J, Zhao L. 2005. Immune responses against SARS-coronavirus nucleocapsid protein induced by DNA vaccine. Virology, 331: 128-135.